Dehydroepiandrosterone (DHEA), Serum
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Diagnosing and differential diagnosis of hyperandrogenism (in conjunction with measurements of other sex steroids)
An initial screen in adults might include dehydroepiandrosterone/dehydroepiandrosterone sulfate and bioavailable testosterone measurement. Depending on results, this may be supplemented with measurements of sex hormone-binding globulin and occasionally other androgenic steroids (eg, 17-hydroxyprogesterone).
An adjunct in the diagnosis of congenital adrenal hyperplasia; dehydroepiandrosterone/dehydroepiandrosterone sulfate measurements play a secondary role to the measurements of cortisol/cortisone, 17 alpha-hydroxyprogesterone, and androstenedione.
Diagnosing and differential diagnosis of premature adrenarche
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
DHEA (Dehydroepiandrosterone) Unconjugated